Race to find better COVID-19 treatments for outpatients
NCT ID NCT05954286
Summary
This study tested experimental drugs to treat COVID-19 early and prevent infection in people recently exposed. It involved 92 adults who either had mild-to-moderate COVID-19 symptoms or were healthy contacts of infected people. Researchers compared new treatments against standard care to see which helped people recover faster and prevented severe illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Josha Research
Bloemfontein, 9300, South Africa
-
KUR Research
Nashville, Tennessee, 37209, United States
-
Makerere University Walter Reed Project
Fort Portal, Uganda
-
Royal Thai Army Clinical Research Center (RTA CRC) Royal Thai Army-Armed Forces Research Institute of Medical Sciences (RTA-AFRIMS)
Bangkok, 10400, Thailand
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.